1. Home
  2. TTEC vs FLNA Comparison

TTEC vs FLNA Comparison

Compare TTEC & FLNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TTEC Holdings Inc.

TTEC

TTEC Holdings Inc.

HOLD

Current Price

$1.53

Market Cap

67.0M

Sector

Technology

ML Signal

HOLD

FLNA

Filana Therapeutics Inc. Common Stock

BUY

Current Price

$0.65

Market Cap

61.8M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
TTEC
FLNA
Founded
1982
1998
Country
United States
United States
Employees
69400
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
67.0M
61.8M
IPO Year
1996
2000

Fundamental Metrics

Financial Performance
Metric
TTEC
FLNA
Price
$1.53
$0.65
Analyst Decision
Buy
Buy
Analyst Count
3
2
Target Price
$4.00
★ $6.50
AVG Volume (30 Days)
402.9K
★ 702.8K
Earning Date
11-05-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 40.80
N/A
EPS
★ N/A
N/A
Revenue
★ $1,509,171,000.00
$41,119,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.71
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 2.15
N/A
52 Week Low
$1.18
$0.64
52 Week High
$3.99
$2.03

Technical Indicators

Market Signals
Indicator
TTEC
FLNA
Relative Strength Index (RSI) 52.09 34.93
Support Level $1.19 N/A
Resistance Level $2.84 $1.05
Average True Range (ATR) 0.12 0.04
MACD 0.00 -0.02
Stochastic Oscillator 52.70 3.74

Price Performance

Historical Comparison
TTEC
FLNA

About TTEC TTEC Holdings Inc.

TTEC Holdings Inc provides customer engagement management tools and services. The company operates through two operating segment, TTEC Digital and TTEC Engage. TTEC Digital is engaged in building and implementing cloud-based and on-premises customer experience tools that enable clients to develop customer engagement strategies. TTEC Engage focuses on delivering sales and marketing solutions to help clients boost their revenue as well as on managing customer's front-to-back office processes to optimize the customer experience. TTEC Engage contributes the vast majority of the company's revenue, and its revenues are derived from the United States and Canada, followed by Philippines, Asia-Pacific and India.

About FLNA Filana Therapeutics Inc. Common Stock

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Share on Social Networks: